CALGB # [001]

Related by string. CALGB # [002] * : CALGB . Group B CALGB / # [012] . # [007] . # [016] . #s [002] . # [014] . #s [004] . # [004] . # [022] . -# [001] . # [009] : #.# ov #-# . #-#:# pm [001] . ID # # . i Newswire #-#-# . Call #-#-# [002] . #-#-# #ET Copyright c . #-#-# ATS [003] . Tel +#-#-#-# Email sales@marketsandmarkets.Ebenezer Scrooge Jim Carrey . #-#-# ATS [002] . +#-#-#-# [004] * *

Related by context. Frequent words. (Click for all words.) 60 temsirolimus 60 Phase 2a trial 60 castration resistant prostate cancer 59 CoFactor 59 Taxotere ® 58 EORTC 58 vandetanib 58 HRPC 58 tesmilifene 58 dasatinib 58 decitabine 57 Jevtana 57 tocilizumab 57 Bevacizumab 57 bone metastasis 57 HGS ETR1 57 Cardiovascular Risk 57 Phase 1b 57 MDV# 57 Imatinib 57 androgen independent 57 metastatic renal cell carcinoma 57 recurrent ovarian cancer 57 randomized Phase III 57 Phenoptin 57 gefitinib 57 hormone refractory prostate cancer 57 mCRC 57 sustained virologic response 57 SUTENT 56 biologic therapy 56 nilotinib 56 PXD# 56 BAY #-# 56 cardiovascular morbidity 56 dose escalation trial 56 Phase 2b study 56 Monotherapy 56 phase IIa 56 imetelstat 55 phase IIb 55 ASA# 55 limiting toxicity 55 colorectal tumors 55 Metastatic Breast Cancer 55 Phase 2b trial 55 substudy 55 IMGN# 55 metastatic colorectal cancer 55 resistant ovarian cancer 55 dosing regimens 55 randomized clinical 55 Phase Ib 55 COPAXONE R 55 Rosuvastatin 55 sunitinib 55 antiplatelet therapy 55 TORISEL 55 randomized controlled clinical 54 Zerenex 54 bone metastases 54 Avastin bevacizumab 54 hepatocellular carcinoma 54 placebo controlled trials 54 LymphoStat B 54 cetrorelix 54 LIALDA 54 Sorafenib 54 multicenter clinical 54 Amigal 54 FDG PET 54 PCa 54 Torisel 54 composite endpoint 54 secondary endpoint 54 adalimumab 54 tolerated dose MTD 54 adjuvant therapy 54 noninferiority 54 PROMACTA 54 non inferiority 54 HER2 positive breast cancer 54 VIDAZA 54 valopicitabine 54 Phase IIa trial 54 Metastatic 54 lupus nephritis 54 refractory multiple myeloma 53 NSCLC 53 pazopanib 53 AP# [003] 53 eltrombopag 53 EGFR mutations 53 peginterferon alfa 2a 53 eGFR 53 myelodysplastic syndromes MDS 53 multicentre 53 B CLL 53 Vectibix 53 panitumumab 53 Everolimus

Back to home page